Posted inMedical Technology Novocure hit by cyberattack exposing patient data September 1, 2026 Novocure has become the latest medtech company to be hit by a cyberattack, with the oncology specialist revealing that unauthorized…
Posted inMedical Technology Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule September 1, 2026 Medtronic is recalling certain esophageal pH monitoring capsule delivery devices amid risks of them failing whilst deployed.
Posted inMedical Technology Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’ September 1, 2026 Boston Scientific has told its customers to stop using its Imager II angiographic catheters upon learning that a manufacturing issue…
Posted inMedical Technology Natera teams with Angiex on cancer drug trial monitoring August 31, 2026 Natera inked a collaboration deal with biotech Angiex to assess the use of its Signatera blood test, which looks for…
Posted inMedical Technology Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drug August 27, 2026 Roche has been given an extended clearance by the FDA for its tests that can find patients eligible to use…
Posted inMedical Technology FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis August 26, 2026 The FDA has approved Abbott’s first-of-its-kind bio-wearable sensor that can warn diabetics of increased ketones that can lead to diabetic…
Posted inMedical Technology Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business August 26, 2026 This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest…
Posted inMedical Technology Labcorp launches new hepatitis D test to find patients with most severe form of virus August 25, 2026 Labcorp is looking to plug the gap in hepatitis D monitoring with a new reflex testing solution to help find…
Posted inMedical Technology Implantica finally nabs FDA approval 8 years after EU green light for reflux implant August 25, 2026 The FDA has signed off on Implantica’s gastroesophageal reflux disease (GERD) implant as the medtech eyes a lucrative U.S. market.
Posted inMedical Technology Qiagen appoints new chief executive after 9-month search August 24, 2026 Molecular diagnostics specialist Qiagen has a new CEO as Jonathan M. Pratt takes the reins.